Skip to main content

Your search for “Drug Development” returned 1007 results

Private Support to UC San Diego Tops $130 Million for 2011-12 Fiscal Year

October 25, 2012

…pioneering molecular approach to drug delivery that could change the pharmaceutical industry worldwide. Steve and Susan Hart The number of alumni giving to UC San Diego significantly increased during fiscal 2011-12. Cymer, a leading developer of light sources used by chipmakers worldwide, made a generous donation to build the Conference…

New Skin Patch Brings Us Closer to Wearable, All-In-One Health Monitor

February 15, 2021

UC San Diego engineers have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer’s levels of glucose as well as lactate, alcohol or caffeine. It performs as well as several commercial devices in one.

Trailblazing Tritons: Notable Alumni Forge Diverse Paths

May 18, 2017

…professor of Neonatal and Developmental Pediatrics in the Department of Pediatrics, both at the Stanford University School of Medicine. Prior to his post at Stanford, he was the director of Family Health at the Bill and Melinda Gates Foundation, where he often traveled to India on the foundation’s behalf and…

Forecasting a Pandemic

May 28, 2020

…modeler. That means she develops mathematical models of the ways infectious diseases are transmitted, then uses the models to evaluate and predict the effects of various public health interventions and other variables. Most recently, she has applied her talents to tracking and forecasting potential COVID-19 transmission on campus, as leader…

Bringing Rigor Back to Science: SciCrunch Supports New NIH Requirements for Biological Citations

June 1, 2016

Ensuring research reproducibility is far from a purely intellectual pursuit: A lack of diligence and consistency can have real-world implications that erode the public’s confidence in scientific research.

UC President Makes First Visit to UC San Diego

November 4, 2021

…discoveries, such as the drug Marizomib. It was developed from a marine cyanobacteria discovered by Scripps scientists, and is now in the final phase of clinical trials to treat the brain cancer glioblastoma. To conclude the visit, President Drake visited the Hydraulics Laboratory for a preview of the new Scripps…

Minding Time

April 18, 2019

…treated with appropriate, rigorously developed psychopharmaceuticals. Judd devoted the rest of his career to building one of the country’s finest psychiatry departments, based on research and evidence, elevating it to among the top three in National Institutes of Health funding. From 1987 to 1990, he served as director of the…

A Look Back at 2022

December 15, 2022

As we look forward to the upcoming new year, UC San Diego Today invites readers to take a look back at some milestones from 2022.

Celebrating the successes of UC San Diego’s most dynamic grads

June 14, 2018

…on aiding in the development of a revolutionary infusion pump,” he said of an engineering project he’s working on. “After this point, I hope to apply the knowledge I’ve gained to make the world a better place through technology and innovation. Regardless of where I end up, I look forward…

Microbial DNA in Patient Blood May be Tell-Tale Sign of Cancer

March 11, 2020

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages.

Category navigation with Social links